Literature DB >> 26742462

The lymphatic system and pancreatic cancer.

Darci M Fink1, Maria M Steele1, Michael A Hollingsworth2.   

Abstract

This review summarizes current knowledge of the biology, pathology and clinical understanding of lymphatic invasion and metastasis in pancreatic cancer. We discuss the clinical and biological consequences of lymphatic invasion and metastasis, including paraneoplastic effects on immune responses and consider the possible benefit of therapies to treat tumors that are localized to lymphatics. A review of current techniques and methods to study interactions between tumors and lymphatics is presented.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Lymph node; Lymphatics; Pancreatic cancer

Mesh：

Year:  2015        PMID： 26742462      PMCID： PMC4969225          DOI： 10.1016/j.canlet.2015.11.048

Source DB:  PubMed          Journal:  Cancer Lett        ISSN： 0304-3835            Impact factor:   8.679


  406 in total

Review 1.  Lymphatic system: a prospective area for advanced targeting of particulate drug carriers.

Authors:  Indu Singh; Rajan Swami; Wahid Khan; Ramakrishna Sistla
Journal:  Expert Opin Drug Deliv       Date:  2013-12-19       Impact factor: 6.648

2.  Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma.

Authors:  H E Wiley; E B Gonzalez; W Maki; M T Wu; S T Hwang
Journal:  J Natl Cancer Inst       Date:  2001-11-07       Impact factor: 13.506

Review 3.  Significance and mechanism of lymph node metastasis in cancer progression.

Authors:  Kenji Kawada; Makoto M Taketo
Journal:  Cancer Res       Date:  2011-01-06       Impact factor: 12.701

4.  Factors in intraductal papillary mucinous neoplasms of the pancreas predictive of lymph node metastasis.

Authors:  Kiichiro Kobayashi; Yoshihiko Sadakari; Takao Ohtsuka; Shunichi Takahata; Masafumi Nakamura; Kazuhiro Mizumoto; Masao Tanaka
Journal:  Pancreatology       Date:  2011-01-18       Impact factor: 3.996

5.  Lack of functioning intratumoral lymphatics in colon and pancreas cancer tissue.

Authors:  Waldemar L Olszewski; Marek Stanczyk; Magdalena Gewartowska; Anna Domaszewska-Szostek; Marek Durlik
Journal:  Lymphat Res Biol       Date:  2012-09       Impact factor: 2.589

6.  GATA2 and Lmo2 control angiogenesis and lymphangiogenesis via direct transcriptional regulation of neuropilin-2.

Authors:  Silvia Coma; Marc Allard-Ratick; Tomoshige Akino; Laurens A van Meeteren; Akiko Mammoto; Michael Klagsbrun
Journal:  Angiogenesis       Date:  2013-07-28       Impact factor: 9.596

7.  Extralymphatic tumors prepare draining lymph nodes to invasion via a T-cell cross-tolerance process.

Authors:  Olivier Preynat-Seauve; Emmanuel Contassot; Prisca Schuler; Vincent Piguet; Lars E French; Bertrand Huard
Journal:  Cancer Res       Date:  2007-05-15       Impact factor: 12.701

8.  Effect of CCR7, CXCR4 and VEGF-C on the lymph node metastasis of human pancreatic ductal adenocarcinoma.

Authors:  Jinghui Guo; Wenhui Lou; Yuan Ji; Shuncai Zhang
Journal:  Oncol Lett       Date:  2013-03-15       Impact factor: 2.967

9.  BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis.

Authors:  Scott M Wilhelm; Christopher Carter; Liya Tang; Dean Wilkie; Angela McNabola; Hong Rong; Charles Chen; Xiaomei Zhang; Patrick Vincent; Mark McHugh; Yichen Cao; Jaleel Shujath; Susan Gawlak; Deepa Eveleigh; Bruce Rowley; Li Liu; Lila Adnane; Mark Lynch; Daniel Auclair; Ian Taylor; Rich Gedrich; Andrei Voznesensky; Bernd Riedl; Leonard E Post; Gideon Bollag; Pamela A Trail
Journal:  Cancer Res       Date:  2004-10-01       Impact factor: 13.312

10.  Pancreatic trypsinogen and cathepsin B in human pancreatic carcinomas and associated metastatic lesions.

Authors:  T Ohta; T Terada; T Nagakawa; H Tajima; H Itoh; L Fonseca; I Miyazaki
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640
View more
  13 in total

Review 1.  Small molecule inhibitors in pancreatic cancer.

Authors:  Jufeng Sun; Cecilia C Russell; Christopher J Scarlett; Adam McCluskey
Journal:  RSC Med Chem       Date:  2020-01-24

2.  Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer.

Authors:  Jason S Lewis; Wolfgang A Weber; Christian Lohrmann; Eileen M O'Reilly; Joseph A O'Donoghue; Neeta Pandit-Taskar; Jorge A Carrasquillo; Serge K Lyashchenko; Shutian Ruan; Rebecca Teng; Wolfgang Scholz; Paul W Maffuid
Journal:  Clin Cancer Res       Date:  2019-09-20       Impact factor: 12.531

3.  Combined targeting of TGF-β, EGFR and HER2 suppresses lymphangiogenesis and metastasis in a pancreatic cancer model.

Authors:  Jesse Gore; Imade E Imasuen-Williams; Abass M Conteh; Kelly E Craven; Monica Cheng; Murray Korc
Journal:  Cancer Lett       Date:  2016-06-03       Impact factor: 8.679

4.  Prognostic Significance of Microvascular Invasion in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis.

Authors:  Huangbao Li; Weiwei Pan; Liu Xu; Dong Yin; Shuqun Cheng; Fengqing Zhao
Journal:  Med Sci Monit       Date:  2021-08-16

5.  Listeria delivers tetanus toxoid protein to pancreatic tumors and induces cancer cell death in mice.

Authors:  Benson Chellakkan Selvanesan; Dinesh Chandra; Wilber Quispe-Tintaya; Arthee Jahangir; Ankur Patel; Kiran Meena; Rodrigo Alberto Alves Da Silva; Madeline Friedman; Lisa Gabor; Olivia Khouri; Steven K Libutti; Ziqiang Yuan; Jenny Li; Sarah Siddiqui; Amanda Beck; Lydia Tesfa; Wade Koba; Jennifer Chuy; John C McAuliffe; Rojin Jafari; David Entenberg; Yarong Wang; John Condeelis; Vera DesMarais; Vinod Balachandran; Xusheng Zhang; Ken Lin; Claudia Gravekamp
Journal:  Sci Transl Med       Date:  2022-03-23       Impact factor: 19.319

6.  Lymph node metastasis and the physicochemical micro-environment of pancreatic ductal adenocarcinoma xenografts.

Authors:  Lise Mari K Andersen; Catherine S Wegner; Trude G Simonsen; Ruixia Huang; Jon-Vidar Gaustad; Anette Hauge; Kanthi Galappathi; Einar K Rofstad
Journal:  Oncotarget       Date:  2017-07-18

Review 7.  The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives.

Authors:  Shun Wang; Yan Zheng; Feng Yang; Le Zhu; Xiao-Qiang Zhu; Zhe-Fang Wang; Xiao-Lin Wu; Cheng-Hui Zhou; Jia-Yan Yan; Bei-Yuan Hu; Bo Kong; De-Liang Fu; Christiane Bruns; Yue Zhao; Lun-Xiu Qin; Qiong-Zhu Dong
Journal:  Signal Transduct Target Ther       Date:  2021-07-05

8.  The siRNA silencing of DcR3 expression induces Fas ligand-mediated apoptosis in HepG2 cells.

Authors:  Tuanjie Zhao; Yingchen Xu; Shulin Ren; Chaojie Liang; Xiaona Zhou; Jixiang Wu
Journal:  Exp Ther Med       Date:  2018-03-19       Impact factor: 2.447

9.  Pathomorphological features of metastatic lymph nodes as predictors of postoperative prognosis in pancreatic cancer.

Authors:  Mayumi Hoshikawa; Sho Ogata; Makoto Nishikawa; Akifumi Kimura; Takahiro Einama; Takuji Noro; Suefumi Aosasa; Kazuo Hase; Hironori Tsujimoto; Hideki Ueno; Junji Yamamoto
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

10.  Lymphatic vessel remodeling and invasion in pancreatic cancer progression.

Authors:  Chia-Ning Shen; King-Siang Goh; Chi-Ruei Huang; Tsai-Chen Chiang; Chih-Yuan Lee; Yung-Ming Jeng; Shih-Jung Peng; Hung-Jen Chien; Mei-Hsin Chung; Ya-Hsien Chou; Chi-Che Hsieh; Subhash Kulkarni; Pankaj J Pasricha; Yu-Wen Tien; Shiue-Cheng Tang
Journal:  EBioMedicine       Date:  2019-09-05       Impact factor: 8.143
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.